Literature DB >> 6802749

A new murine lymphocyte alloantigen, Ly-21.2, mapping to the seventh chromosome.

J Kennard, D Meruelo.   

Abstract

Using a monoclonal antibody raised by fusing spleen cells from A/J mice, immunized with B10.A splenocytes and lymph-node cells, with a BALB/c myeloma, we have described a new surface alloantigen, Ly-21.2, Ly-21.2 is present in varying amounts in all lymphoid tissues, is not detectable in the brain, kidney, lung or erythrocytes, and is found in only trace amounts in the liver. Strain distribution studies showed that Ly-21.2 is present in all strains examined, including B10, except the A strain and segregation analysis of (A/J x B10) F2 mice showed that Ly-21.2 expression (1) is encoded by one gene and (2) is linked to albinism on chromosome 7. Studies performed on mice developing T-cell leukemia showed that, regardless of the etiologic agent, Ly-21.2 expression increases dramatically in mice with overt leukemia. In addition, preliminary studies suggest that expression of Ly-21.2 is linked to increased susceptibility of mice to Friend-virus-induced erythroleukemia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802749     DOI: 10.1007/BF00364332

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  24 in total

1.  Host-induced changes in infectivity of Friend spleen focus-forming virus.

Authors:  R A Steeves; R J Eckner
Journal:  J Natl Cancer Inst       Date:  1970-03       Impact factor: 13.506

2.  ASSAY FOR FRIEND LEUKEMIA VIRUS: RAPID QUANTITATIVE METHOD BASED ON ENUMERATION OF MACROSCOPIC SPLEEN FOCI IN MICE.

Authors:  A A AXELRAD; R A STEEVES
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

3.  Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex.

Authors:  B Chesebro; K Wehrly
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

4.  An alloantigen selective for B cells: Ly-17.1.

Authors:  F W Shen; E A Boyse
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

5.  Definition of a new T lymphocyte cell surface antigen, Ly 11.2.

Authors:  D Meruelo; A Paolino; N Flieger; M Offer
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

6.  Mechanism of genetic resistance to Friend virus leukemia in mice. V. Relevance of Fv-3 gene in the regulation of in vivo immunosuppression.

Authors:  V Kumar; P Resnick; J W Eastcott; M Bennett
Journal:  J Natl Cancer Inst       Date:  1978-10       Impact factor: 13.506

7.  Qat-4 and Qat-5, new murine T-cell antigens governed by the Tla region and identified by monoclonal antibodies.

Authors:  G J Hämmerling; U Hämmerling; L Flaherty
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

8.  Rfv-1 and Rfv-2, two H-2-associated genes that influence recovery from Friend leukemia virus-induced splenomegaly.

Authors:  B Chesebro; K Wehrly
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

9.  Thy-2: a murine thymocyte-brain alloantigen controlled by a gene linked to the major histocompatibility complex.

Authors:  A W Siadak; R C Nowinski
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

10.  Host genetic control of recovery from Friend leukemia virus-induced splenomegaly: mapping of a gene within the major histocompatability complex.

Authors:  B Chesebro; K Wehrly; J Stimpfling
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

View more
  3 in total

1.  Ly-15.2 and Ly-21.2 are distinct polymorphisms of the LFA-1 heavy chain.

Authors:  P M Hogarth; I F McKenzie
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Genetic nomenclature for loci controlling mouse lymphocyte antigens.

Authors:  H C Morse; F W Shen; U Hämmerling
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

Review 3.  Optimality and heuristics in perceptual neuroscience.

Authors:  Justin L Gardner
Journal:  Nat Neurosci       Date:  2019-02-25       Impact factor: 24.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.